Marked improvement in bone mineral density (BMD) for patients (pts) with monoclonal gammopathy of undetermined significance (MGUS) using zoledronic acid (ZOL)James R. Berenson, R. Swift, Ralph V. Boccia et al.|Journal of Clinical Oncology|2008Cited by 2